| scholarly article | Q13442814 |
| P2093 | author name string | Valter C Lima | |
| Domingos S N Lima | |||
| Emilia I Sato | |||
| Fausto Miranda | |||
| Francisca H Hatta | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| endothelium | Q111140 | ||
| P304 | page(s) | 292-297 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Brachial endothelial function is impaired in patients with systemic lupus erythematosus | |
| P478 | volume | 29 |
| Q37369357 | A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus |
| Q47871866 | Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus. |
| Q84430476 | Atherosclerosis risk factors in systemic lupus erythematosus |
| Q35543444 | Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus |
| Q87461934 | Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study |
| Q61797294 | Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features |
| Q37425906 | Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors |
| Q35777047 | Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis |
| Q35144681 | Common carotid artery intima-media thickness is useful for diagnosis of the acute stage of Kawasaki disease |
| Q47389819 | Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy |
| Q48858141 | Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis. |
| Q35940072 | Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus |
| Q40459503 | Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. |
| Q34027430 | Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease |
| Q51607486 | Endothelial dysfunction in Iranian lupus patients. |
| Q34072179 | Endothelial dysfunction in chronic inflammatory diseases |
| Q41260389 | Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression |
| Q35553196 | Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity |
| Q36012874 | Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification |
| Q35552153 | Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis |
| Q36136279 | Endotoxin-induced and vaccine-induced systemic inflammation both impair endothelium-dependent vasodilation, but not pulse wave reflection |
| Q38066385 | Global trends, potential mechanisms and early detection of organ damage in SLE. |
| Q85849984 | Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus |
| Q35587694 | High dietary fat promotes visceral obesity and impaired endothelial function in female mice with systemic lupus erythematosus |
| Q35450156 | Imaging assessment of cardiovascular disease in systemic lupus erythematosus |
| Q37699812 | Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. |
| Q37206972 | Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. |
| Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
| Q89779990 | Microvascular Disease and Small-Vessel Disease: The Nexus of Multiple Diseases of Women |
| Q89947833 | No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus |
| Q40297850 | Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients |
| Q30409882 | Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus |
| Q43874384 | Omega-3: a double-edged sword for autoimmune diseases |
| Q33387473 | Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study |
| Q35552242 | Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study |
| Q54961260 | Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery. |
| Q33714074 | Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study. |
| Q34346294 | Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness. |
| Q84256255 | Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus |
| Q79934477 | Subclinical impairment of arterial mechanics in systemic lupus erythematosus identified by arterial waveform analysis |
| Q37233020 | The pathophysiology of hypertension in systemic lupus erythematosus |
| Q37230796 | Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease |
| Q38777852 | Understanding mechanisms of hypertension in systemic lupus erythematosus |
| Q36908457 | Von Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus |
| Q81772558 | [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?] |
Search more.